Menu

Converting Fear to Realistic and Actionable Hope

| Yelak Biru

In his pre-2014 IMF ASH write-up, Dr. Durie said, “This year, there doesn’t appear to be the sort of news that will reset the needle in the myeloma landscape.” However, last year, Dr. Keith Stewart’s ASPIRE presentation about Progression Free Survival (PFS) of 26+ months (vs. 17 with Rd) was one of the main highlights […]

Coordinating Doses of Daily Hope

| Robin Tuohy

For more than five decades, the ASH annual meeting has served as the premier event for scientific exchange in the field of hematology. Today, this meeting attracts more than 20,000 attendees from all over the world. Since 2006, the IMF has provided a unique opportunity for support group leaders to attend ASH.  This year we […]

15-Year Myeloma Survivor Reports from ASH

| Michael Tuohy

When I was diagnosed in 2000, only a handful of treatment options were available. We used our options sparingly, hoping to keep something in our back pocket for when we needed it. Today is a very different story. We have treatment options that use various types of drugs that can work alone and in combination […]